Quick Ratio
Higher than 100% of Healthcare sector peers
Updated 1054h ago
Sector Performance
100th percentileKROS
22.11x
Sector Median
1.31x
Sector Avg
2.65x
Deep Analysis
Keros Therapeutics, Inc. (KROS) has a Quick Ratio of 22.11x as of May 2026.
This places KROS in the 100th percentile of the Healthcare sector, which has a median Quick Ratio of 1.31x and a sector average of 2.65x. KROS's Quick Ratio is 1581.4% above the sector median, a significant divergence that warrants closer examination. In context: A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
Frequently Asked Questions
What does the Quick Ratio tell investors about KROS?
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
How is the Quick Ratio calculated?
Quick Ratio is calculated as: (Cash + Receivables) / Current Liabilities.
How does KROS's Quick Ratio compare to its sector?
KROS's Quick Ratio of 22.11x compares to a Healthcare sector median of 1.31x, placing it in the 100th percentile.
Who are KROS's closest peers by Quick Ratio?
The closest Healthcare peers by Quick Ratio include: BIO (1.02x), BAX (1.01x), BSX (1.00x), BMY (0.91x), DGX (0.91x).
The Formula
(Cash + Receivables) / Current Liabilities
Why It Matters
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
Master KROS's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full KROS research report →KROS
22.11x
Sector Median
1.31x
Sector Avg
2.65x
How KROS's Quick Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.